Evidence map›Paper›PMID 26362295›Full record

ArticleInfectious diseases and therapy2015

Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists.

Mark Gilchrist, Paul Wade, Diane Ashiru-Oredope, Philip Howard, Jacqueline Sneddon, Laura Whitney, Hayley Wickens

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antimicrobial resistance profiles ofJAC-antimicrobial resistance · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 1 country.

Mark GilchristImperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. mark.gilchrist@imperial.nhs.uk.
Paul WadeGuy's and St. Thomas' NHS Foundation Trust, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Diane Ashiru-OredopeAntimicrobial Resistance Programme, Public Health England, London, UK.
Philip HowardLeeds Teaching Hospitals NHS Trust, Great George Street, Leeds, LS1 3EX, UK.
Jacqueline SneddonScottish Antimicrobial Prescribing Group, Healthcare Improvement Scotland, 50 West Nile Street, Glasgow, G1 2NP, UK.
Laura WhitneySt George's University Hospital NHS Foundation Trust, Blackshaw Road, Tooting, London, SW17 0QT, UK.
Hayley WickensUniversity Hospital Southampton NHS Foundation Trust, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
Healthcare Improvement Scotland · GBImperial College Healthcare NHS Trust · GBLeeds Teaching Hospitals NHS Trust · GBPublic Health England · GBSouthampton General Hospital · GBSt George’s University Hospitals NHS Foundation Trust · GBSt Thomas' Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial stewardship in the UK has evolved dramatically in the last 15 years. Factors driving this include initial central funding for specialist pharmacists and mandatory reductions in healthcare-associated infections (particularly Clostridium difficile infection). More recently, the introduction of national stewardship guidelines, and an increased focus on stewardship as part of the UK five-year antimicrobial resistance strategy, have accelerated and embedded developments. Antimicrobial pharmacists have been instrumental in effecting changes at an organizational and national level. This article describes the evolution of the antimicrobial pharmacist role, its impact, the progress toward the actions listed in the five-year resistance strategy, and novel emerging areas in stewardship in the UK.

Indexed as

AntibioticAntimicrobial stewardshipHealthcare-associated infectionsPharmacyResistance

Identifiers

PMID26362295
PMCPMC4569645
OpenAlexW2166761591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.